Perfusion Systems Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-vivo Organ Perfusion System), By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global perfusion systems market size was valued at USD 1.07 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030. Factors such as increase in prevalence of cardiovascular and respiratory diseases, rise in number of organ transplantation, growth in geriatric population and multiple organ failures are expected to drive the growth of the market.Other factors such as increasing investment in cell-based research, government and NGO initiatives to encourage organ donation and rise in biologic manufacturing are also expected to boost the market growth over the forecast period. The COVID-19 pandemic that affected almost every country around the world and led to a major loss of life had a slightly negative impact on the market. While the cardiac surgeries were still carried out due to the chronic nature and the life-threatening risk that it possesses, there was a significant drop in number of organ donations and transplants during the pandemic due to the lockdowns and restrictions imposed by the government. Thus, the market experienced significant fall in sales of perfusion system during the pandemic.

Moreover, the lockdowns and restrictions led by the government disrupted the manufacturing processes as well as the overall supply chain. It also resulted in disruption of research and development activities which may have resulted in postponement of launch of new products in the market. In addition, reduced patient visits to the hospital as a precautionary measure to avoid contracting the virus also had a significant negative impact on the market.

However, with the world now returning to normalcy and the countries majorly focusing on healthcare, the perfusion system market is expected to continue generating significant amount of revenue during the forecast period. With launch of new products, the market is expected to experience pre-covid growth rate over the forecast period.

Rise in prevalence of cardiac and respiratory diseases is majorly contributing towards the growth of perfusion system market. Factors such as increasing consumption of processed foods, reduced physical activities and increase in overall lifespan of individuals, which has resulted in increase in number of geriatric population is leading to a rise in prevalence of cardiac and respiratory diseases. According to the CDC’s 2022 data, in the U.S., every year about 805,000 people have a heart attack and out of this 605,000 people are those who get it for the first time.

Rise in number of organ transplants is another factor that is expected to boost the market growth to a great extent over the forecast period. According to the preliminary data of United Network of Organ Sharing, in 2021, the U.S. observed a 5.9 percent rise in organ transplants from 2020. The data also stated that, in 2021, around 13,861 Americans became deceased organ donors.

Application Insights

The cardiopulmonary perfusion system held the highest share of more than 44.30% in 2022 owing to the increasing prevalence of cardiovascular & respiratory diseases and a rapid rise in the number of organ transplant procedures being carried across the globe.

The Ex-vivo organ perfusion system is getting popularity in the recent years. This is because the ex-vivo perfusion system has the capability to allow organs to survive longer outside the body and make immediate transplant less urgent. This further helps the number of organs available for transplant to grow.

The cardiopulmonary perfusion system is further classified into oxygenators, heart-lung machine, perfusion pumps, cannula, monitoring system and others. The oxygenator segment held the largest share in 2022 owing to the rising incidence of cardiopulmonary failure.

The cell perfusion system is further segmented into bioreactor perfusion system, microfluidic perfusion system, gravity/pressure-driven perfusion system and small mammal organ perfusion system. The bioreactor perfusion system dominated the cell perfusion system segment with highest share in 2022. This is attributed towards factors such as, rising demand for biological products and constant need to increase product yield & reduce production costs.

The Ex-vivo organ perfusion system is further segmented into hypothermic and normothermic. The hypothermic segment accounted for highest market share in 2022. This can be attributed towards the advantages that hypothermic perfusion system offers such as, better long-term graft survival rates, ability to provide metabolic support and decreased vasospasm.

Regional Insights

North America dominated the perfusion system market with the highest market share of 39.64% in 2022. This is attributed towards enormous healthcare spending and advantageous health cover policies by both government and private insurers. Growing number of organ donors is a major factor contributing towards the growth of perfusion system in this region. According to the Health Resources & Services Administration, in U.S., more than 40,000 transplants were carried out in 2021.

However, Asia Pacific region is projected to undergo maximum growth during the forecast period. Factors such as increase in geriatric population, shift towards sedentary lifestyle which is contributing towards a rise in the prevalence of chronic diseases are driving the growth of the market in this region. Various government initiatives in this region is also anticipated to boost the growth of perfusion systems market. Moreover, countries like India and China, where the number of patients in need of organ transplant is way higher than the number of organ donors, which is a cause of concern for the government and healthcare officials and therefore these countries are focusing on developing various strategies to promote organ donation.

Key Companies & Market Share Insights

Key players manufacturing perfusion systems are focusing on various strategic initiatives to boost their market presence and overall position in the market. Launch of new products, strategic acquisitions and mergers and partnerships are some of the initiatives carried out by the key players to strengthen their position in the market. For instance, in April 2022, LivaNova announced the commercial launch of Essenz patient monitor. The monitor uses a patient-tailored approach to improve efficiency and quality of care during cardiopulmonary bypass (CPB) procedures. Some of the prominent key players operating in the perfusion systems market include:

• Getinge AB

• Medtronic, plc

• LivaNova

• Terumo Corporation

• Nipro Corporation

• XENIOS AG

• Repligen Corporation

• Spectrum Laboratories, Inc.

• Merck KGaA

• Harvard Bioscience, Inc.

• ALA Scientific Instruments, Inc.

• Lifeline Scientific, Inc.

• XVIVO Perfusion AB

Perfusion Systems Market Report Scope

Global Perfusion Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global perfusion systems market report on the basis of application, and region:

• Application Outlook (Revenue in USD Million; 2018 - 2030)

  • Cardiopulmonary Perfusion System

    • Oxygenators

    • Heart-Lung Machine

    • Perfusion Pumps

    • Cannula

    • Monitoring System

    • Others

  • Cell Perfusion System

    • Bioreactor Perfusion System

    • Microfluidic Perfusion System

    • Gravity/Pressure-driven Perfusion System

    • Small Mammal Organ Perfusion System

  • Ex-Vivo Organ Perfusion System

    • Hypothermic

    • Normothermic

• Regional Outlook (Revenue in USD Million; 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Singapore

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE